| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.31B | 53.48B | 50.47B | 53.82B | 50.67B | 29.71B |
| Gross Profit | 17.28B | 19.87B | 18.20B | 18.81B | 18.65B | 9.73B |
| EBITDA | 8.96B | 11.67B | 11.35B | 12.65B | 13.47B | 5.25B |
| Net Income | 5.90B | 8.12B | 6.44B | 7.35B | 8.13B | 2.66B |
Balance Sheet | ||||||
| Total Assets | 86.62B | 83.23B | 87.86B | 73.47B | 71.33B | 51.79B |
| Cash, Cash Equivalents and Short-Term Investments | 23.61B | 21.34B | 20.83B | 16.55B | 12.41B | 10.69B |
| Total Debt | 13.21B | 10.06B | 14.02B | 15.87B | 10.42B | 7.81B |
| Total Liabilities | 26.38B | 21.84B | 29.43B | 25.85B | 30.21B | 20.29B |
| Stockholders Equity | 60.24B | 61.39B | 58.44B | 47.22B | 40.73B | 31.18B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.33B | 8.00B | 99.81M | 1.13B | 2.62B |
| Operating Cash Flow | 0.00 | 10.37B | 9.67B | 2.83B | 6.40B | 5.31B |
| Investing Cash Flow | 0.00 | -4.76B | -2.77B | -2.75B | -6.60B | -2.57B |
| Financing Cash Flow | 0.00 | -5.13B | -3.52B | 3.96B | 1.93B | -2.44B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥89.22B | 6.87 | ― | 1.72% | 36.31% | 101.77% | |
77 Outperform | ¥600.71B | 24.84 | 12.66% | 2.28% | 9.53% | -11.17% | |
76 Outperform | ¥303.78B | 15.35 | 5.77% | 3.28% | 11.15% | -19.39% | |
71 Outperform | ¥181.92B | 51.88 | 10.10% | 1.00% | -12.50% | -26.08% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
50 Neutral | ¥648.33B | -42.71 | ― | 1.14% | 0.66% | -87.63% | |
50 Neutral | ¥108.19B | -7.98 | ― | 2.45% | 4.60% | -21.64% |